vs

Side-by-side financial comparison of PRECISION BIOSCIENCES INC (DTIL) and PARK AEROSPACE CORP (PKE). Click either name above to swap in a different company.

PRECISION BIOSCIENCES INC is the larger business by last-quarter revenue ($34.2M vs $17.3M, roughly 2.0× PARK AEROSPACE CORP). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs 17.0%, a 41.8% gap on every dollar of revenue. On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs 20.3%). PARK AEROSPACE CORP produced more free cash flow last quarter ($4.3M vs $-11.3M). Over the past eight quarters, PRECISION BIOSCIENCES INC's revenue compounded faster (39.5% CAGR vs 3.0%).

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

Park Electrochemical Corp, now called the Park Aerospace Corp, is a Melville, New York-based materials manufacturer for the telecommunications, Internet infrastructure, high-end computing, and aerospace industries. It produces high-technology digital and radio frequency(RF)/microwave printed circuit material products, composite materials. Its printed circuit materials are used for complex multilayer printed circuit boards and other electronic interconnection systems, such as multilayer back-p...

DTIL vs PKE — Head-to-Head

Bigger by revenue
DTIL
DTIL
2.0× larger
DTIL
$34.2M
$17.3M
PKE
Growing faster (revenue YoY)
DTIL
DTIL
+5240.8% gap
DTIL
5261.1%
20.3%
PKE
Higher net margin
DTIL
DTIL
41.8% more per $
DTIL
58.9%
17.0%
PKE
More free cash flow
PKE
PKE
$15.5M more FCF
PKE
$4.3M
$-11.3M
DTIL
Faster 2-yr revenue CAGR
DTIL
DTIL
Annualised
DTIL
39.5%
3.0%
PKE

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
DTIL
DTIL
PKE
PKE
Revenue
$34.2M
$17.3M
Net Profit
$20.1M
$3.0M
Gross Margin
34.1%
Operating Margin
36.6%
21.0%
Net Margin
58.9%
17.0%
Revenue YoY
5261.1%
20.3%
Net Profit YoY
213.5%
87.1%
EPS (diluted)
$2.62
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DTIL
DTIL
PKE
PKE
Q4 25
$34.2M
$17.3M
Q3 25
$13.0K
$16.4M
Q2 25
$18.0K
$15.4M
Q1 25
$29.0K
$16.9M
Q4 24
$638.0K
$14.4M
Q3 24
$576.0K
$16.7M
Q2 24
$49.9M
$14.0M
Q1 24
$17.6M
$16.3M
Net Profit
DTIL
DTIL
PKE
PKE
Q4 25
$20.1M
$3.0M
Q3 25
$-21.8M
$2.4M
Q2 25
$-23.5M
$2.1M
Q1 25
$-20.6M
$1.2M
Q4 24
$1.6M
Q3 24
$-16.4M
$2.1M
Q2 24
$32.7M
$993.0K
Q1 24
$8.6M
$2.7M
Gross Margin
DTIL
DTIL
PKE
PKE
Q4 25
34.1%
Q3 25
31.2%
Q2 25
30.6%
Q1 25
29.3%
Q4 24
26.6%
Q3 24
28.5%
Q2 24
29.3%
Q1 24
27.3%
Operating Margin
DTIL
DTIL
PKE
PKE
Q4 25
36.6%
21.0%
Q3 25
-158976.9%
17.4%
Q2 25
-121538.9%
15.7%
Q1 25
-76248.3%
16.8%
Q4 24
12.8%
Q3 24
-3693.6%
15.7%
Q2 24
48.4%
14.9%
Q1 24
-23.8%
15.7%
Net Margin
DTIL
DTIL
PKE
PKE
Q4 25
58.9%
17.0%
Q3 25
-167476.9%
14.7%
Q2 25
-130666.7%
13.5%
Q1 25
-70913.8%
7.4%
Q4 24
10.9%
Q3 24
-2851.6%
12.4%
Q2 24
65.6%
7.1%
Q1 24
48.8%
16.3%
EPS (diluted)
DTIL
DTIL
PKE
PKE
Q4 25
$2.62
$0.15
Q3 25
$-1.84
$0.12
Q2 25
$-2.13
$0.10
Q1 25
$-2.21
$0.06
Q4 24
$0.08
Q3 24
$-2.25
$0.10
Q2 24
$4.67
$0.05
Q1 24
$1.70
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DTIL
DTIL
PKE
PKE
Cash + ST InvestmentsLiquidity on hand
$115.6M
$63.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$92.2M
$106.6M
Total Assets
$154.4M
$118.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DTIL
DTIL
PKE
PKE
Q4 25
$115.6M
$63.6M
Q3 25
$44.9M
$61.6M
Q2 25
$62.2M
$65.6M
Q1 25
$77.2M
$68.8M
Q4 24
$86.3M
$70.0M
Q3 24
$101.2M
$72.0M
Q2 24
$123.6M
$74.4M
Q1 24
$137.8M
$77.2M
Stockholders' Equity
DTIL
DTIL
PKE
PKE
Q4 25
$92.2M
$106.6M
Q3 25
$16.6M
$105.8M
Q2 25
$34.1M
$105.0M
Q1 25
$49.3M
$107.2M
Q4 24
$56.4M
$107.4M
Q3 24
$64.9M
$110.3M
Q2 24
$74.7M
$111.7M
Q1 24
$37.2M
$112.9M
Total Assets
DTIL
DTIL
PKE
PKE
Q4 25
$154.4M
$118.1M
Q3 25
$93.5M
$116.4M
Q2 25
$108.9M
$120.7M
Q1 25
$124.4M
$122.1M
Q4 24
$136.4M
$124.2M
Q3 24
$153.3M
$125.1M
Q2 24
$165.8M
$129.4M
Q1 24
$184.7M
$132.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DTIL
DTIL
PKE
PKE
Operating Cash FlowLast quarter
$-11.3M
$5.1M
Free Cash FlowOCF − Capex
$-11.3M
$4.3M
FCF MarginFCF / Revenue
-32.9%
24.6%
Capex IntensityCapex / Revenue
0.1%
4.8%
Cash ConversionOCF / Net Profit
-0.56×
1.73×
TTM Free Cash FlowTrailing 4 quarters
$3.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DTIL
DTIL
PKE
PKE
Q4 25
$-11.3M
$5.1M
Q3 25
$-15.3M
$-2.1M
Q2 25
$-20.3M
$1.6M
Q1 25
$-19.1M
$969.0K
Q4 24
$-58.4M
$2.7M
Q3 24
$-5.9M
$1.4M
Q2 24
$-14.9M
$-423.0K
Q1 24
$-19.0M
$5.3M
Free Cash Flow
DTIL
DTIL
PKE
PKE
Q4 25
$-11.3M
$4.3M
Q3 25
$-2.3M
Q2 25
$-20.3M
$1.1M
Q1 25
$-19.1M
$338.0K
Q4 24
$-58.7M
$2.7M
Q3 24
$-6.0M
$1.3M
Q2 24
$-14.9M
$-435.0K
Q1 24
$-19.1M
$5.1M
FCF Margin
DTIL
DTIL
PKE
PKE
Q4 25
-32.9%
24.6%
Q3 25
-14.0%
Q2 25
-112627.8%
7.2%
Q1 25
-65917.2%
2.0%
Q4 24
-9199.8%
18.6%
Q3 24
-1033.2%
7.5%
Q2 24
-29.9%
-3.1%
Q1 24
-108.4%
31.4%
Capex Intensity
DTIL
DTIL
PKE
PKE
Q4 25
0.1%
4.8%
Q3 25
0.0%
1.1%
Q2 25
11.1%
3.1%
Q1 25
220.7%
3.7%
Q4 24
39.2%
0.4%
Q3 24
6.8%
1.2%
Q2 24
0.1%
0.1%
Q1 24
0.5%
1.0%
Cash Conversion
DTIL
DTIL
PKE
PKE
Q4 25
-0.56×
1.73×
Q3 25
-0.88×
Q2 25
0.76×
Q1 25
0.78×
Q4 24
1.73×
Q3 24
0.70×
Q2 24
-0.45×
-0.43×
Q1 24
-2.21×
1.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DTIL
DTIL

Segment breakdown not available.

PKE
PKE

North America$16.8M97%
Other$546.0K3%

Related Comparisons